By Geoff Adams-Spink, Special to CNN
Geoff Adams-Spink was born in 1962 with multiple impairments caused by the drug, thalidomide. He was a BBC journalist for 22 years, and latterly the Age and Disability Correspondent. The views expressed are his own.
So, after a mere half-century, German pharmaceutical firm Gruenenthal has decided to apologize for the devastating effects its drug, thalidomide, had on thousands of babies and their families around the world, myself included. Is this a reason to celebrate? Is it even a reason for cautious optimism, or is it simply a piece of news management designed to salvage what is left of its corporate reputation?
Gruenenthal's chief executive, Harald Stock, made the apology Friday as he inaugurated a memorial to those affected in Stolberg, Germany, where the company is based.
I was aware of Herr Stock long before his name was flashed around newsrooms all over the world when he made his momentous announcement.
Together with others, I've been campaigning for justice for the global thalidomide community for the past decade.